| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 9, 2018 | Cleveland founder shares what his startup community gets right and wrong | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
I’ve had a front-row seat to Cleveland’s startup ... |
| Jun 17, 2013 | Angel groups are investing more but making the money harder to get | Investors say being part of a group solves a lot of problems: They have access to more deals, don’t have to write huge checks to raise a lot of money for a company and can syndicate bigger rounds with other angel networks.
Clay Rankin, who ... |
| Mar 21, 2013 | DecisionDesk nets $1.7M to help colleges & companies pick the best people (exclusive) | Ever had to collect thousands of applications and whittle them down to find the best hundred candidates? Universities and businesses do it all the time, and it’s not an easy task.
New York and Cleveland-based DecisionDesk wants to change th... |
| Mar 21, 2013 | DecisionDesk nets $1.7M to help colleges & companies pick the best people (exclusive) | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Ever had to collect thousands of applications and... |
| Feb 22, 2013 | An entrepreneur’s quick guide to working with angel investors | There’s no one “kind” of angel. Some investors will want to know lots of details about the progress of the company; others will want to be involved in only the big-picture things. Iron out all of those expectations in the beginning. “We’ve ... |
| Feb 14, 2012 | Intelligent Mobile Support Receives $500K in First Funding | Intelligent Mobile Support, a Cleveland, OH-based cloud-computing company connecting mobile employees to experts and information, has raised an additional $250k in funding from North Coast Angel Fund.
This funding, combined with investments... |
| Dec 7, 2011 | Meet Ohio’s angel investors (and see what they want in a company) | It’s likely only a fraction of the angel investment that happens in Ohio does so through the tax credit program. But all that other data isn’t public record, so the tax credit investment information from the state is the best we’ve got.
Cas... |
| Oct 31, 2011 | Neuros Medical looks to close $3.5M round, begin pilot clinical study | More importantly, it would help pave the way for a pivotal, approximately 100-patient trial of the device aimed at obtaining U.S. Food and Drug Administration clearance. The FDA’s stamp of approval would represent Neuros’ most consequential... |
| Sep 29, 2011 | Ohio’s investor tax credit: Who’s using it (and who isn’t) | What’s more, while $1.5 million is the maximum investment amount that can be raised with the tax credit, only 80 companies have even raised $750,000 in equity toward the credit. Only 11 companies have raised essentially the maximum.
In life... |
| Sep 19, 2011 | TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients | The company is reformulating a drug — sodium nitrite — for the treatment of peripheral artery disease (PAD), a condition in which narrowed arteries reduce blood flow to the limbs. The condition often afflicts diabetics and can result in the... |
| Aug 15, 2011 | Ohio fund tops list of biggest angel investment groups | Each of the two Ohio funds are active healthcare investors. North Coast Angels recently led a $3.4 million series A round for wound therapy startup SironRX Therapeutics. Other North Coast portfolio companies include drug developer TheraVasc... |
| Jul 5, 2011 | Peripheral artery disease pill from TheraVasc heading to phase 2a trials | The company is reformulating a drug — sodium nitrite — for the treatment of PAD, a condition in which narrowed arteries reduce blood flow to the limbs. The condition often afflicts diabetics and can result in the amputation of patients’ fee... |
| Apr 6, 2011 | Neuros Medical reports positive results from study of pain-blocking device | Neuros is developing a device that uses a pacemaker-sized generator and an electrode to stimulate nerves to block pain from amputations — sometimes called stump pain — without the use of drugs. Last year, Neuros received a $1.2 million gran... |
| Jan 18, 2011 | Neuros Medical reports early results from study of pain-blocking device | The company hopes to complete the feasibility study near the middle of 2011 after enrolling about five more patients. Neuros is likely three or four years away from applying for regulatory clearance to sell the device, Snyder said.
The Will... |
| Nov 23, 2010 | North Coast Angel Fund back in fundraising mode | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Sep 27, 2010 | Peripheral artery disease drug developer TheraVasc raises $1.8M | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| Jul 6, 2010 | Neuros Medical wins $1.5 million DoD grant | By Mary Vanac
Neuros Medical Inc. plans to double — maybe even triple — its employment over the coming year as it uses a $1.5 million U.S. Dept. of Defense grant to speed development of its neurostimulation device to block chronic pain.
The... |
| Jul 2, 2010 | Neuros Medical gets $1.5M defense award for pain-blocking device | The grant also will enable Neuros to hire between two and six product and clinical development staff members within 12 months. “We want to expand the team here to support the efforts going forward,” Snyder said. Neuros now employs three peo... |
| Jan 6, 2010 | Columbus venture group Ohio TechAngel Funds raises $2.5M for third fund | In Ohio, these groups and the economic development  organizations that often support them have received millions of grant dollars from the Ohio Third Frontier project.
Some of that support is starting to show. Huston said his first Tech... |
| Oct 23, 2009 | Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors | Initially, the device is being developed to block residual limb pain caused by complications of amputations, as well as chronic pain after surgery and migraine pain.
Neuros Medical will use the investors’ money to kick off product developm... |
| May 12, 2009 | CerviLenz closes on $4 million Series A round to create preterm pregnancy detector | “What we’re trying to do is when we go to market have all the evidence for adoption,” said Dean Koch, a former vice president at the women’s health manufacturer Adeza who is now CerviLenz’s chief executive officer.
Arboretum Ventures and ... |
| Jan 21, 2009 | Venture newcomer Portal Capital could fund 3 companies in 2009 | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| Ohio fund tops list of biggest angel investment groups | The Ohio TechAngel Fund tops a list of the nation’s biggest angel investor groups by Entrepreneur.com.
With 282 members, the Columbus, Ohio-based group was one of just three angel groups to boast more than 200 members. Los Angeles’s Tech Co... |
| Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors | CLEVELAND, Ohio — Neuros Medical Inc., a start-up company that is developing a neurostimulation device to block chronic pain, has landed $1.8 million from several investors during its first round of venture financing.
North Coast Angel F... |
| Meet Ohio’s angel investors (and see what they want in a company) | Angel investors are a secretive bunch.
They generally prefer to stay out of the limelight and let the companies they invest in receive the attention. But thanks to a state-sponsored tax credit, at least some of the investment activity by Oh... |
| Neuros Medical looks to close $3.5M round, begin pilot clinical study | Neurostimulation company Neuros Medical is looking to collect a $3.5 million round of investment that it would use to launch a pilot study of its pain-relief device.
After earlier this year completing the first successful in-man feasibility... |
| Columbus venture group Ohio TechAngel Funds raises $2.5M for third fund | COLUMBUS, Ohio — Early stage venture group Ohio TechAngel Funds has raised $2.5 million for its third investment fund, according to a regulatory filing.
Like the group’s previous funds, Ohio TechAngel Fund III will invest in Ohio-based te... |
| CerviLenz closes on $4 million Series A round to create preterm pregnancy detector | CHAGRIN FALLS, Ohio — Cleveland-area medical device maker CerviLenz Inc. has closed on a $4 million funding round that will take its product, which promises to help cut the number of preterm births, through clinical trials and into the mark... |
| Venture newcomer Portal Capital could fund 3 companies in 2009 | BEACHWOOD, Ohio — An under-the-radar investment fund hopes to make two to three deals in the life sciences sector this year and focus its efforts on Northeast Ohio startups.
Portal Capital, which started early last year, closed one deal las... |
| Ohio’s investor tax credit: Who’s using it (and who isn’t) | People love talking about the value of getting investor tax credits. Companies seem to love applying for tax credits.
Using the investor tax credit? That’s different.
A total of 590 companies have been approved for Ohio’s Technology Investm... |
| Neuros Medical reports positive results from study of pain-blocking device | Neurotechnology startup Neuros Medical reported encouraging results from the first in-human study of its device that blocks pain for amputation patients.
The Willoughby, Ohio, company said that four of five patients in the study reported th... |
| Neuros Medical gets $1.5M defense award for pain-blocking device | Neuros Medical Inc. plans to double — maybe even triple — its employment over the coming year as it uses a $1.5 million U.S. Department of Defense grant to speed development of its neurostimulation device to block chronic pain.
The Willough... |
| An entrepreneur’s quick guide to working with angel investors | The number of angel investors in the U.S. has jumped 60 percent since 2002, and the number of dollars they’ve invested in companies has gone up even faster. Not to mention that a few new angel groups have sprouted just within the last year ... |
| TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients | A phase 1 trial of a peripheral artery disease drug candidate from TheraVasc demonstrated safety in diabetic patients.
The positive clinical trial data reported by Cleveland-based TheraVasc potentially puts the young company one step closer... |
| DecisionDesk Raises $1.7M to Continue Innovation of the Application Process | 332SHARES
FacebookTwitter
Linkedin
In a sea of qualified applicants, finding the right one can seem daunting. DecisionDesk saves businesses and universities time and money by letting them quickly access, filter and review video auditions an... |
| Neuros Medical reports early results from study of pain-blocking device | Neuros Medical announced positive early results in the first-ever in-human feasibility study of its pain-blocking device.
In a 30-day test focused on one patient with chronic residual limb pain, the amputation patient reported a reduction i... |
| North Coast Angel Fund back in fundraising mode | Early stage investment group North Coast Angel Fund is raising money for a second fund, having made an initial closing of $800,000, according to a regulatory document.
Considering the group’s first fund totaled $5.6 million, it’s a near cer... |
| Angel groups are investing more but making the money harder to get | This is the second of a two-part series on the evolution of angel investing. To read part one, click here.
As groups of high-net-worth individuals continue to band together in the form of angel investment networks and funds, they’re creatin... |
| Peripheral artery disease pill from TheraVasc heading to phase 2a trials | TheraVasc plans to begin enrolling patients this month in a phase 2a clinical trial of its pill designed to treat peripheral artery disease.
The clinical trial, which is expected to follow 50 diabetic PAD patients for 11 weeks, could lead t... |
| Peripheral artery disease drug developer TheraVasc raises $1.8M | TheraVasc Inc., which is reformulating a drug to treat vascular diseases, has raised $1.8 million in its first round of investment capital.
The funding comes from existing investors JumpStart Inc. and Portal Capital, and new investors North... |
